Your session is about to expire
← Back to Search
Arm A Cyclosporine for SARS
Study Summary
This trial will test if an oral formulation of cyclosporine can help treat COVID-19.
- SARS
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Why is Arm A Cyclosporine often recommended?
"Arm A Cyclosporine is a medication that is frequently used to treat patients post-transplant. It can also be effective in treating conditions such as lupus nephritis, bulla, and excessive tearing."
Are there other ongoing research projects that use Arm A Cyclosporine?
"There are 71 active clinical trials worldwide that are studying Arm A Cyclosporine. Out of those, 13 studies are in Phase 3. While a few Assiut-based sites are finishing up their research, there are 475 other locations running trials for Arm A Cyclosporine."
Is Arm A Cyclosporine a safe medication for patients to take?
"While Arm A Cyclosporine has not yet been proven effective, it did receive a score of 2 because there is some clinical data supporting its safety."
What is the total number of participants in this trial?
"That is correct, the online information from clinicaltrials.gov reveals that this study is still currently enrolling patients. The trial was originally advertised on November 23rd 2020 with the most recent update being October 26th 2021. They are looking for a total of 75 individuals across 1 location."
If I qualify, who can sign up for this clinical study?
"Researchers are looking for 75 individuals, within the ages of 18 and 90 who have contracted covid-19. Furthermore, it is essential that these participants also meet the following clinical criteria: 3.1.2 Patients admitted to non-ICU hospital floors or in an emergency department awaiting admission to a non-ICU hospital bed., 3.1.3 WHO COVID Scale Score 4 (Oxygen by mask or nasal prongs or WHO COVID Scale Score 5 (non-invasive ventilation or high-flow oxygen)., 3.1.4 Age 18 to 90 years old., 3.1.5 ECOG ("
Does age play a role in patients' ability to join this trial?
"As long as they are between 18-90 years old, patients satisfy the age criteria for this study."
Is this study still enrolling participants?
"The study, which as of 10/26/2021 is still recruiting patients, was originally posted on 11/23/2020."
Share this study with friends
Copy Link
Messenger